D-Index & Metrics Best Publications
Fabien Zoulim

Fabien Zoulim

Microbiology
France
2023
Medicine
France
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 108 Citations 47,173 721 World Ranking 141 National Ranking 6
Medicine D-index 108 Citations 47,573 753 World Ranking 3492 National Ranking 88

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in France Leader Award

2023 - Research.com Microbiology in France Leader Award

2022 - Research.com Microbiology in France Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Virus

The scientist’s investigation covers issues in Hepatitis B virus, Virology, Hepatitis B, Immunology and Internal medicine. His Hepatitis B virus research is classified as research in Virus. His Virology study frequently links to other fields, such as Molecular biology.

Fabien Zoulim has included themes like Nucleoside analogue, Viral load, Liver disease and Entecavir, Lamivudine in his Hepatitis B study. The various areas that Fabien Zoulim examines in his Immunology study include Liver cancer, Hepatocellular carcinoma and Drug resistance. The concepts of his Internal medicine study are interwoven with issues in Gastroenterology, Pegylated interferon and Pathology.

His most cited work include:

  • EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. (1745 citations)
  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B (1528 citations)
  • A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness (841 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns Virology, Hepatitis B virus, Internal medicine, Hepatitis B and Immunology. His research combines Molecular biology and Virology. HBsAg, Hepadnaviridae, HBeAg, Lamivudine and cccDNA are subfields of Hepatitis B virus in which his conducts study.

His studies deal with areas such as Gastroenterology and Ribavirin as well as Internal medicine. His biological study spans a wide range of topics, including Nucleoside analogue, Viral hepatitis, Hepatitis, Liver disease and Entecavir. His research on Immunology often connects related areas such as Drug resistance.

He most often published in these fields:

  • Virology (72.75%)
  • Hepatitis B virus (60.47%)
  • Internal medicine (30.76%)

What were the highlights of his more recent work (between 2017-2021)?

  • Hepatitis B virus (60.47%)
  • Internal medicine (30.76%)
  • Virology (72.75%)

In recent papers he was focusing on the following fields of study:

Fabien Zoulim mainly investigates Hepatitis B virus, Internal medicine, Virology, Gastroenterology and Hepatitis B. His Hepatitis B virus research includes themes of Coinfection, Genome and Viral replication. His Internal medicine study combines topics in areas such as HBsAg and Hepatitis C virus.

Carcinogenesis is closely connected to Genotype in his research, which is encompassed under the umbrella topic of Virology. His work in Gastroenterology addresses issues such as Hepatitis C, which are connected to fields such as Sofosbuvir and Antibody. Hepatitis B is a primary field of his research addressed under Immunology.

Between 2017 and 2021, his most popular works were:

  • Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study (179 citations)
  • A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis. (149 citations)
  • A global scientific strategy to cure hepatitis B (119 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Virus

Hepatitis B virus, Internal medicine, Hepatitis B, Cirrhosis and Gastroenterology are his primary areas of study. His study on Hepatitis B virus is covered under Virology. His research investigates the connection between Internal medicine and topics such as HBsAg that intersect with problems in Clinical trial, Cmax, Loading dose and Area under the curve.

Hepatitis B is a subfield of Immunology that Fabien Zoulim tackles. Fabien Zoulim interconnects Liver transplantation, CD8 and Myocardial infarction in the investigation of issues within Cirrhosis. His Gastroenterology research incorporates themes from Pharmacokinetics, Hepatitis C, Cmin and Hepatitis C virus.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.

Pietro Lampertico;Kosh Agarwal;Thomas Berg;Maria Buti.
Journal of Hepatology (2017)

4071 Citations

EASL Clinical Practice Guidelines: Management of chronic hepatitis B

C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban.
Journal of Hepatology (2009)

2451 Citations

A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness

Lieven Stuyver;Sija De Gendt;Caroline Van Geyt;Fabien Zoulim.
Journal of General Virology (2000)

1273 Citations

Persistence of cccDNA During the Natural History of Chronic Hepatitis B and Decline During Adefovir Dipivoxil Therapy

Bettina Werle-Lapostolle;Scott Bowden;Stephen Locarnini;Karsten Wursthorn;Karsten Wursthorn.
Gastroenterology (2004)

1130 Citations

Statements from the Taormina expert meeting on occult hepatitis B virus infection.

Giovanni Raimondo;Jean Pierre Allain;Maurizia R. Brunetto;Marie Annick Buendia.
Journal of Hepatology (2008)

1063 Citations

Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

Lars Petter Jordheim;David Durantel;Fabien Zoulim;Charles Dumontet.
Nature Reviews Drug Discovery (2013)

774 Citations

Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management.

Anna S. Lok;Fabien Zoulim;Stephen Locarnini;Angeline Bartholomeusz.
Hepatology (2007)

677 Citations

Hepatitis B virus resistance to nucleos(t)ide analogues.

Fabien Zoulim;Fabien Zoulim;Stephen Locarnini.
Gastroenterology (2009)

607 Citations

Woodchuck hepatitis virus X protein is required for viral infection in vivo.

F Zoulim;J Saputelli;C Seeger.
Journal of Virology (1994)

582 Citations

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890

Christophe Hézode;Hélène Fontaine;Céline Dorival;Dominique Larrey.
Journal of Hepatology (2013)

540 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Fabien Zoulim

Harry L.A. Janssen

Harry L.A. Janssen

University Health Network

Publications: 154

Maria Buti

Maria Buti

Instituto de Salud Carlos III

Publications: 145

Stephen Locarnini

Stephen Locarnini

Melbourne Health

Publications: 140

Jia-Horng Kao

Jia-Horng Kao

National Taiwan University

Publications: 133

Heiner Wedemeyer

Heiner Wedemeyer

Hannover Medical School

Publications: 126

Sang Hoon Ahn

Sang Hoon Ahn

Yonsei University

Publications: 124

Man-Fung Yuen

Man-Fung Yuen

University of Hong Kong

Publications: 121

Stefan Zeuzem

Stefan Zeuzem

Goethe University Frankfurt

Publications: 116

Yasuhito Tanaka

Yasuhito Tanaka

Kumamoto University

Publications: 115

Patrick Marcellin

Patrick Marcellin

Université Paris Cité

Publications: 114

Masashi Mizokami

Masashi Mizokami

Nagoya City University

Publications: 111

Michael P. Manns

Michael P. Manns

Hannover Medical School

Publications: 110

Bettina E. Hansen

Bettina E. Hansen

University Health Network

Publications: 108

Ching-Lung Lai

Ching-Lung Lai

University of Hong Kong

Publications: 106

Henry Lik-Yuen Chan

Henry Lik-Yuen Chan

Chinese University of Hong Kong

Publications: 104

Pei-Jer Chen

Pei-Jer Chen

National Taiwan University

Publications: 100

Trending Scientists

Yen-Fu Chen

Yen-Fu Chen

University of Warwick

Katsuyuki Haneda

Katsuyuki Haneda

Aalto University

Ali Elkamel

Ali Elkamel

University of Waterloo

Martyn P. Nash

Martyn P. Nash

University of Auckland

Carlos A. Bacino

Carlos A. Bacino

Baylor College of Medicine

John B. Vincent

John B. Vincent

Centre for Addiction and Mental Health

Kit M. Kovacs

Kit M. Kovacs

Norwegian Polar Institute

Milan Gelnar

Milan Gelnar

Masaryk University

John M. Pawelek

John M. Pawelek

Yale University

Wendy C. Moore

Wendy C. Moore

Wake Forest University

Scott D. Lane

Scott D. Lane

The University of Texas Health Science Center at Houston

Peter T. Donnan

Peter T. Donnan

University of Dundee

Peter R. Donald

Peter R. Donald

Stellenbosch University

John J. Clement

John J. Clement

University of Massachusetts Amherst

Maria Polinsky

Maria Polinsky

University of Maryland, College Park

Stefan Timmermans

Stefan Timmermans

University of California, Los Angeles

Something went wrong. Please try again later.